Question

Difficulty: HardDepressive Disorders

Match each patient's clinical presentation with the most appropriate next step in psychopharmacologic or procedural management.

  • A 72-year-old man with major depressive disorder refuses to eat or drink for 4 days, resulting in acute kidney injury. He is actively hallucinating that his internal organs are rotting.Schedule for immediate electroconvulsive therapy
  • A 58-year-old man presents with depressed mood, anhedonia, and insomnia 4 weeks after an acute anterior wall myocardial infarction. He is clinically stable on his current cardiac medications.Initiate sertraline monotherapy
  • A 24-year-old man with newly diagnosed major depressive disorder reports severe insomnia and weight loss. He has a history of epilepsy on levetiracetam and requests a treatment lacking sexual side effects.Initiate mirtazapine monotherapy
  • A 45-year-old woman on escitalopram 20 mg daily for 8 weeks reports only partial improvement in her depressive symptoms. She continues to struggle with profound daytime fatigue and poor concentration.Add bupropion to the current regimen
  • A 62-year-old woman with breast cancer presents with major depression. She recently started tamoxifen therapy. She requests medication to improve her mood and manage severe concurrent hot flashes.Initiate venlafaxine monotherapy

Answer

The 72-year-old man with food refusal requires electroconvulsive therapy. The 58-year-old man post-myocardial infarction requires sertraline. The 24-year-old man with epilepsy requires mirtazapine. The 45-year-old woman with residual fatigue requires bupropion augmentation. The 62-year-old woman on tamoxifen requires venlafaxine.
Each patient requires a highly specific intervention based on their medical comorbidities and symptom profiles. Electroconvulsive therapy is required for life-threatening psychotic depression. Sertraline is chosen for post-myocardial infarction safety. Mirtazapine is selected to avoid sexual dysfunction in a patient who cannot take bupropion due to epilepsy. Bupropion is added to an SSRI for partial response with residual fatigue. Venlafaxine is chosen to avoid CYP2D6 interactions with tamoxifen while also effectively treating concurrent hot flashes.

Step-by-Step Solution

1
Analyze the 72-year-old man's presentation.
Severe major depressive disorder with psychotic features and life-threatening oral refusal.
Identify the need for an emergent, rapid-acting intervention (electroconvulsive therapy) over slower-acting pharmacotherapy.
2
Evaluate the 58-year-old man's medical history.
Recent myocardial infarction requires a cardiac-safe antidepressant.
Sertraline is the best-studied and safest SSRI for patients with recent ischemic cardiac events.
3
Assess the 24-year-old man's specific requests and absolute contraindications.
Needs an agent without sexual side effects but cannot take bupropion due to epilepsy.
Mirtazapine avoids sexual dysfunction, does not significantly lower the seizure threshold, and addresses his concurrent severe insomnia.
4
Review the 45-year-old woman's treatment progress.
Partial response to an SSRI with persistent residual fatigue and poor concentration.
Bupropion augmentation is the standard next step to target these specific residual symptoms without discontinuing the partially effective SSRI.
5
Determine safe oncologic and psychiatric options for the 62-year-old woman on tamoxifen.
Must avoid CYP2D6 inhibitors to maintain tamoxifen efficacy, while also treating vasomotor symptoms.
Venlafaxine lacks significant CYP2D6 inhibition and is a first-line non-hormonal treatment for severe hot flashes.

Key Concept

Management of major depressive disorder must be strictly tailored to the patient's specific symptom profile, medical comorbidities, concurrent medications, and the acuity of the clinical situation.
Estimated Time:3m 0s
Rate this question